Join us on May 16th to uncover the mysteries of gene and cell therapy, presented by GE Healthcare & CCRM, a leader in developing and commercializing regenerative medicine technologies and cell and gene therapies. Hear from Director of BridGE@CCRM, Aaron Dulgar-Tulloch, as he provides an in-depth discussion on "Cell & Gene Therapy - Manufacturing Considerations.”
Before the presentation from Aaron, tour CCRM's new facility in the MaRS West Tower before heading to JLABS @ Toronto for the presentation and product showcase.
BridGE@CCRM offers technology development for GE Healthcare and external partners and process development services for cell and gene therapy. In addition to the presentation, GE will provide several product demonstrations by GE specialists. Several new products have been added to the GE Life Sciences portfolio including HyClone; WAVE bioreactors; Filtration; ÄKTA chromatography; Imaging equipment; Biacore; RTP Columns; Fast Track; Dharmacon and Cell Therapy. Stop by for this seminar and to discuss your research, process development, and production needs.
Aaron Dulgar-Tulloch | Director, BridGE@CCRM, GE Healthcare
Aaron Dulgar-Tulloch is Director of BridGE@CCRM for GE Healthcare’s Cell Therapy Technologies. BridGE@CCRM is a GE collaboration with CCRM that with the Government of Canada has created a Centre for Advanced Therapeutic Cell Technologies to offer technology development for GE Healthcare and external partners and process development services for cell and gene therapy manufacturers. Prior to this, Aaron has served in a variety of management and scientific positions with GE Healthcare and GE Global Research. Aaron earned his Ph.D. in Materials Science and Engineering from Rensselaer Polytechnic Institute focusing on biomaterials and mesenchymal stem cells and his Bachelor of Science in Engineering in Chemical and Biological Engineering from Princeton University.
Connect with Aaron:
10:00 AM | Registration & Networking at CCRM
10:30 AM | Tour of CCRM
10:45 AM | Travel to JLABS @ Toronto
11:00 AM | Presentation
12:00 PM | Product Showcase, Lunch and Networking*
1:00 PM | Program Close
*Light food & beverage provided
Who should attend:
This workshop is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.
There is no cost to attend this workshop, but pre-registration is required.
JLABS @ Toronto
661 University Ave, Suite 1300
Save This Event
When & Where
JLABS @ Toronto
Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.